Minoxidil/finasteride

Minoxidil/finasteride
Minoxidil
Finasteride
Combination of
MinoxidilPotassium channel opener
Finasteride5α-Reductase inhibitor
Clinical data
Trade namesMorrF; Morr F
Other namesFinasteride/minoxidil
Routes of
administration		Topical[1]
Drug classHair loss medication

Minoxidil/finasteride, or finasteride/minoxidil, sold under the brand name MorrF or Morr F, is a combination of the KATP potassium channel opener minoxidil and the 5α-reductase inhibitor finasteride which is approved and used in the treatment of alopecia (hair loss) in India.[1][2][3] It is used topically.[1] The drug was developed by Intas Pharmaceuticals and Jina Pharmaceuticals and was introduced in 2015.[1]

References

  1. ^ a b c d "Jina Pharmaceuticals/Intas Pharmaceuticals". AdisInsight. 2 September 2015. Retrieved 23 October 2025.
  2. ^ Ramkar S, Kaurav M, Sudheesh MS, Pandey RS (January 2023). "Enhanced skin penetration of Finasteride loaded DMSO-liposomes for the treatment of androgenic alopecia: comparison with conventional liposomes". Drug Development and Industrial Pharmacy. 49 (1): 52–61. doi:10.1080/03639045.2023.2182122. PMID 36803490.
  3. ^ van Hoogevest P, Tiemessen H, Metselaar JM, Drescher S, Fahr A (2021). "The Use of Phospholipids to Make Pharmaceutical Form Line Extensions". European Journal of Lipid Science and Technology. 123 (4) 2000297. doi:10.1002/ejlt.202000297. ISSN 1438-7697. Retrieved 23 October 2025.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.